Phase 1 Keratitis Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis
Neurotrophic Keratitis
Krystal Biotech, Inc.60 enrolled9 locationsNCT06999733
Recruiting
Phase 1Phase 2
Clinical Study of Intrastromal Anti-VEGF Injection for Corneal Neovascularization.
Herpes Simplex KeratitisCorneal Neovascularization
Second Affiliated Hospital, School of Medicine, Zhejiang University100 enrolled1 locationNCT07329686
Not Yet Recruiting
Phase 1
A Phase-I, randomised controlled trial (RCT) of Ultraviolet C (UVC) light therapy to assess ocular surface safety
Microbial keratitis
The University of Auckland22 enrolled1 locationACTRN12625001173482
Recruiting
Phase 1
Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking
Bacterial KeratitisEctasia of CorneaKeratoconus, Unstable
Pacific Clear Vision Institute300 enrolled1 locationNCT03918408